Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial

BACKGROUND: Thrice-weekly haemodialysis is the usual dose when starting renal replacement therapy; however, this schedule is no longer appropriate since it does not consider residual renal function. Several reports have suggested the potential benefit of beginning haemodialysis less frequently and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Lucas, M., Ruíz-Roso, G., Merino, J. L., Sánchez, R., Bouarich, H., Herrero, J. A., Muriel, A., Zamora, J., Collado, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031943/
https://www.ncbi.nlm.nih.gov/pubmed/32075665
http://dx.doi.org/10.1186/s13063-020-4058-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031943/
https://www.ncbi.nlm.nih.gov/pubmed/32075665
http://dx.doi.org/10.1186/s13063-020-4058-0

Ejemplares similares